Fay Burrows

536 total citations
14 papers, 203 citations indexed

About

Fay Burrows is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Fay Burrows has authored 14 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Fay Burrows's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Respiratory viral infections research (3 papers). Fay Burrows is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Respiratory viral infections research (3 papers). Fay Burrows collaborates with scholars based in Australia, New Zealand and France. Fay Burrows's co-authors include Deborah Marriott, Hergen Buscher, Susan Welch, M. Plit, Allan R. Glanville, A. Havryk, M.A. Malouf, Steven C. Wallis, John F. Fraser and Kiran Shekar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Emerging infectious diseases and Clinical Pharmacokinetics.

In The Last Decade

Fay Burrows

13 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fay Burrows Australia	7	84	80	45	41	35	14	203
Sam Rudham Australia	7	103 1.2×	57 0.7×	71 1.6×	26 0.6×	39 1.1×	8	180
Stefano Cristallini Belgium	5	168 2.0×	75 0.9×	116 2.6×	46 1.1×	46 1.3×	8	270
Hyo Jung Park South Korea	11	79 0.9×	48 0.6×	28 0.6×	61 1.5×	60 1.7×	33	281
Jerry Altshuler United States	10	90 1.1×	68 0.8×	10 0.2×	44 1.1×	48 1.4×	24	278
Christel Johanson Canada	8	116 1.4×	53 0.7×	24 0.5×	48 1.2×	16 0.5×	9	337
Simone Lindau Germany	10	27 0.3×	48 0.6×	28 0.6×	37 0.9×	20 0.6×	21	250
Paweł Piwowarczyk Poland	10	45 0.5×	37 0.5×	21 0.5×	119 2.9×	26 0.7×	37	256
Carlos Metz Germany	8	69 0.8×	115 1.4×	54 1.2×	37 0.9×	47 1.3×	14	388
Jörn Grensemann Germany	11	52 0.6×	57 0.7×	35 0.8×	96 2.3×	19 0.5×	47	304
William Darko United States	10	96 1.1×	64 0.8×	11 0.2×	29 0.7×	86 2.5×	38	311

Countries citing papers authored by Fay Burrows

Since Specialization

Citations

This map shows the geographic impact of Fay Burrows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fay Burrows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fay Burrows more than expected).

Fields of papers citing papers by Fay Burrows

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fay Burrows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fay Burrows. The network helps show where Fay Burrows may publish in the future.

Co-authorship network of co-authors of Fay Burrows

This figure shows the co-authorship network connecting the top 25 collaborators of Fay Burrows. A scholar is included among the top collaborators of Fay Burrows based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fay Burrows. Fay Burrows is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Burrows, Fay, et al.. (2024). Crossing the Turbulent Hepatitis Sea: Use of Prophylactic Glecaprevir/Pibrentasvir to Facilitate Cardiothoracic Transplants from Hepatitis C Viremic Donors in Australia. The Journal of Heart and Lung Transplantation. 43(4). S452–S452.

Burrows, Fay, et al.. (2023). It cuts both ways: A single-center retrospective review describing a three-way interaction between flucloxacillin, voriconazole and tacrolimus. International Journal of Antimicrobial Agents. 62(3). 106908–106908. 1 indexed citations

Patterson, Caroline, Elaine C. Jolly, Fay Burrows, N.J. Ronan, & Haifa Lyster. (2023). Conventional and Novel Approaches to Immunosuppression in Lung Transplantation. Clinics in Chest Medicine. 44(1). 121–136. 7 indexed citations

Abdul‐Aziz, Mohd H., Fay Burrows, Hergen Buscher, et al.. (2022). Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study). Clinical Pharmacokinetics. 61(6). 847–856. 13 indexed citations

Abdul‐Aziz, Mohd H., Fay Burrows, Hergen Buscher, et al.. (2022). Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study). Anaesthesia Critical Care & Pain Medicine. 41(3). 101080–101080. 6 indexed citations

Li, Jonathan, Cindy Lau, Naomi Anderson, et al.. (2022). Multispecies Outbreak of Nocardia Infections in Heart Transplant Recipients and Association with Climate Conditions, Australia. Emerging infectious diseases. 28(11). 2155–2164. 4 indexed citations

Abdul‐Aziz, Mohd H., Fay Burrows, Hergen Buscher, et al.. (2021). Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study). International Journal of Antimicrobial Agents. 58(6). 106466–106466. 19 indexed citations

Burrows, Fay, M. Plit, A. Havryk, et al.. (2020). An Exclusively Oral Ribavirin Regimen for Respiratory Syncytial Virus Infection after Lung Transplantation is Effective and Cost-Efficient. The Journal of Heart and Lung Transplantation. 39(4). S95–S95. 1 indexed citations

Breeding, Jeff, et al.. (2018). Sound and light in ICU during different environmental conditions. Australian Critical Care. 31(2). 135–135. 1 indexed citations

10.

Burrows, Fay, Deborah Marriott, A. Havryk, et al.. (2015). Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency. The Journal of Heart and Lung Transplantation. 34(7). 958–962. 56 indexed citations

11.

Burrows, Fay, et al.. (2013). Oral Ribavirin Is a Cost-Effective Alternative to Intravenous Ribavirin for Respiratory Syncytial Virus (RSV) Infection after Lung Transplantation (LTx). The Journal of Heart and Lung Transplantation. 32(4). S109–S109. 2 indexed citations

12.

Shekar, Kiran, Jason A. Roberts, Susan Welch, et al.. (2012). ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO. SHILAP Revista de lepidopterología. 73 indexed citations

13.

Breeding, Jeff, et al.. (2012). Medication Error Minimization Scheme (MEMS) in an adult tertiary Intensive Care Unit (ICU) 2009–2011. Australian Critical Care. 26(2). 58–75. 17 indexed citations

14.

Shekar, Kiran, Jason A. Roberts, Susan Welch, et al.. (2012). ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO. BMC Anesthesiology. 12(1). 29–29. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact